- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
VEEV
MEX
Week ended 24 Jul 2026
Weekly Investor Report
Veeva Systems Inc. · Healthcare · Health Information Services
Latest close
3,430 MXN
0.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 6.9% above the Trend Line and sits at 26.8% of its 52-week range. The latest completed week returned 0.0%, after a 15.5% four-week move. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.
Setup score
34
out of 100
Latest Close
3,430 MXN
24 Jul 2026
1W Return
0.0%
latest completed week
4W Return
15.5%
short-term follow-through
12W Return
22.7%
quarterly tape
Trend Breadth
30.8%
16 of 52 weeks active
Volume Ratio
0.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 29.07% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.0%
Latest completed week; four-week move 15.5%.
Indicator stack
17/96
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 29.07%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
53/100
27 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 6.9% above the Trend Line and sits at 26.8% of its 52-week range. The latest completed week returned 0.0%, after a 15.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.0x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0812-week average 0.03
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.08Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 15.5% over four weeks, 22.7% over 12 weeks, and -36.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year16
Trend breadth30.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.32Latest activity-pressure read.
Pressure change272.8%Four-week change in activity pressure.
Leadership-16.13Latest relative-leadership reading.
RS change49.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 27 relevant articles.
5 positive · 21 neutral · 1 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-39.2%Distance below the 52-week high.
13-week volatility6.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher11 of 269 weeks finished lower.
Best week+12.4%Week of 26 Jun.
Worst week-19.8%Week of 10 Apr.
Latest week+0.0%Week of 24 Jul.
Shape of recent returns
Strong gains7
Modest gains4
Flat weeks6
Modest losses2
Sharp losses7
Recent vol6.1%13-week weekly-return volatility.
Base vol6.5%52-week weekly-return volatility.
Up/down split17/21Count of positive and negative weeks in the 52-week window.
Average skew5.9% / -6.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorMX Healthcare
4-week rank3 / 78
Group average0.9%
Trend breadth26.9%
Trend26.9%active weekly trend signals
MD61.5%positive activity pressure
RS32.1%positive relative leadership
Four-week leaders
IndustryMX Health Information Services
4-week rank2 / 2
Group average15.7%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD100.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape27/100
Trend, activity pressure, participation, and risk combine to a 27/100 tape read.
Indicator analysis25/100Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.
Activity pressure 0.08; No reversal markers Next-Week ExpectancyNegative 29.07%Next-week expectancy is negative with a 29.07% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment53/100Weighted news tone is neutral across 27 relevant articles.
Veeva Systems (NYSE: VEEV): Vanguard reports 11.2M-share, 6.89% ownership on Schedule 13G Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 3,430 MXN | 0.0% | 3,208 MXN | 3,995 MXN | 1.32 | -16.13 | 12 | Off |
| 17 Jul 2026 | 3,430 MXN | 2.9% | 3,232 MXN | 3,995 MXN | 1.20 | -17.55 | 90 | Off |
| 10 Jul 2026 | 3,333 MXN | 4.2% | 3,256 MXN | 3,994 MXN | 0.86 | -20.75 | 3.3K | Off |
| 3 Jul 2026 | 3,200 MXN | 7.8% | 3,284 MXN | 3,995 MXN | 0.48 | -25.53 | 77 | Off |
| 26 Jun 2026 | 2,969 MXN | 12.4% | 3,328 MXN | 3,996 MXN | 0.35 | -31.95 | 80 | Off |
| 19 Jun 2026 | 2,641 MXN | -3.8% | 3,375 MXN | 3,999 MXN | 0.16 | -40.77 | 0 | Off |
| 12 Jun 2026 | 2,744 MXN | -9.7% | 3,436 MXN | 4,004 MXN | 0.18 | -39.67 | 36 | Off |
| 5 Jun 2026 | 3,040 MXN | 10.6% | 3,522 MXN | 4,009 MXN | 0.14 | -32.37 | 0 | Off |
| 29 May 2026 | 2,749 MXN | -1.5% | 3,597 MXN | 4,011 MXN | 0.03 | -41.79 | 43 | Off |
| 22 May 2026 | 2,790 MXN | 4.6% | 3,683 MXN | 4,014 MXN | -0.01 | -41.56 | 71 | Off |
| 15 May 2026 | 2,668 MXN | -6.4% | 3,768 MXN | 4,017 MXN | -0.07 | -44.38 | 478 | Off |
| 8 May 2026 | 2,850 MXN | 2.0% | 3,855 MXN | 4,020 MXN | -0.11 | -42.78 | 9.3K | Off |
| 1 May 2026 | 2,795 MXN | 2.9% | 3,948 MXN | 4,022 MXN | -0.38 | -42.83 | 4.1K | Off |
| 24 Apr 2026 | 2,715 MXN | -6.4% | 4,025 MXN | 4,025 MXN | -0.45 | -46.13 | 10.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.